Publication | Closed Access

Multicenter phase-I/II study using a combination of gemcitabine and docetaxel in metastasized and unresectable, locally advanced pancreatic carcinoma

Advanced Pancreatic CarcinomaPancreatic CancerGastrointestinal OncologyMedicineMolecular OncologyCancer TreatmentOncologyRadiation OncologyMulticenter Phase-i/ii StudyRadiologyHealth Sciences